abrdn Life Sciences Investors Shares of Beneficial Interest (HQL)
Stock · NYSE · Finance
$16.76as of 10/16/2026
Price chart
Active signals
HQL Signal Track Record
How signals performed across all stocks →What HQL's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 30 | +2.9% | 67% | July 24, 2026 |
| Bollinger Band Breakdown | 21 | -0.8% | 43% | October 1, 2026 |
| 200-Day Moving Average TouchActive now | 21 | +0.6% | 57% | October 2, 2026 |
| Bollinger Band Breakout | 19 | +1.9% | 63% | August 7, 2026 |
| Any 20-session window (baseline) | +1.0% | 58% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About HQL
Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies…
- Sector
- Finance
- Industry
- Investment Managers
Fundamentals
- 1-day range
- $17.11$17.38
- Market cap
- $518.99M
- P/E (trailing)
- 2.51
- P/E (forward)
- —
- EPS (trailing)
- $6.60
- Dividend yield
- 9.89%
- Beta
- 0.73
- Avg. volume
- 146.0K
- Ex-dividend date
- August 24, 2026
- Dividend pay date
- December 31, 2018
abrdn Life Sciences Investors Shares of Beneficial Interest Competitors
Chosen by industry and closest market cap.
- HQLabrdn Life Sciences Investors Shares of Beneficial Interest$16.78▼ 2.67%Market cap $518.99MP/E 2.51$15.66$22.67
- ETOEaton Vance Tax-Advantage Global Dividend Opp Common Stock$30.19▼ 0.69%Market cap $515.08MP/E 0.16$25.68$32.35
- TYGTortoise Energy Infrastructure Corporation Common Stock$39▲ 1.48%Market cap $501.33MP/E 14.36$37.45$51.18
- RILYPBRC Group Holdings Inc. Depositary Shares each representing a 1/1000th fractional interest in a share of Series A Cumulative Perpetual Preferred Stock$7.9▲ 1.80%Market cap $537.20MP/E 0.45$3.64$11.24
- RILYLBRC Group Holdings Inc. Depositary Shares each representing 1/1000th in a share of 7.375% Series B Cumulative Perpetual Preferred Stock par value $0.0001$8.55▲ 0.06%Market cap $556.70MP/E 0.50$3.64$11.24
- MGRBAffiliated Managers Group Inc. 4.750% Junior Subordinated Notes due 2060$15.31▲ 0.20%Market cap $471.36MP/E 11.40$231.53$395
- MGRAffiliated Managers Group Inc. 5.875% Junior Subordinated Notes due 2059$18.54▼ 0.48%Market cap $569.66MP/E 11.40$231.53$395
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| HQL abrdn Life Sciences Investors Shares of Beneficial Interest | $518.99M | 2.51 | $16.78 | ▼ 2.67% | $15.66$22.67 |
| ETO Eaton Vance Tax-Advantage Global Dividend Opp Common Stock | $515.08M | 0.16 | $30.19 | ▼ 0.69% | $25.68$32.35 |
| TYG Tortoise Energy Infrastructure Corporation Common Stock | $501.33M | 14.36 | $39 | ▲ 1.48% | $37.45$51.18 |
| RILYP BRC Group Holdings Inc. Depositary Shares each representing a 1/1000th fractional interest in a share of Series A Cumulative Perpetual Preferred Stock | $537.20M | 0.45 | $7.9 | ▲ 1.80% | $3.64$11.24 |
| RILYL BRC Group Holdings Inc. Depositary Shares each representing 1/1000th in a share of 7.375% Series B Cumulative Perpetual Preferred Stock par value $0.0001 | $556.70M | 0.50 | $8.55 | ▲ 0.06% | $3.64$11.24 |
| MGRB Affiliated Managers Group Inc. 4.750% Junior Subordinated Notes due 2060 | $471.36M | 11.40 | $15.31 | ▲ 0.20% | $231.53$395 |
| MGR Affiliated Managers Group Inc. 5.875% Junior Subordinated Notes due 2059 | $569.66M | 11.40 | $18.54 | ▼ 0.48% | $231.53$395 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Aberdeen Investments U.S. Closed-End Funds Announce Distribution Payment DetailsYahoo · 9/30/2026
- 10 Best CEFs This Month: Average Yield Of 10% (September 2026)SeekingAlpha · 9/26/2026
- HQL: The Rally That Makes Growth Harder (Rating Downgrade)SeekingAlpha · 9/15/2026
Insider Activity
Insider Actions →- Chris LaVictoire Mahai · July 16, 2026 · Buy527 @ $19.92
Institutional Ownership
March 31, 2026
- Total shares held
- 8.29M
- Total value held
- $119.66M
- Institutional holders
- 86
- Unknown1.57M
- Unknown947.3K
- Unknown806.9K
- Unknown661.3K
- Unknown478.8K
- Unknown429.6K
- Unknown382.7K
- Unknown362.5K
- Unknown198.7K
- Unknown191.8K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
HQL Listed Among Top CEFs for September 2026 Yield
abrdn Life Sciences Investors (HQL) was included in a recent list of the ten best closed-end funds for September 2026, which highlights an average yield of 10%. This inclusion suggests the fund is being noted for its income potential within the broader CEF market. The stock is currently trading near its support level, reflecting a mixed technical picture alongside this fundamental recognition.
HQL Listed Among Top CEFs for September 2026 Yield. abrdn Life Sciences Investors (HQL) was included in a recent list of the ten best closed-end funds for September 2026, which highlights an average yield of 10%. This inclusion suggests the fund is being noted for its income potential within the broader CEF market. The stock is currently trading near its support level, reflecting a mixed technical picture alongside this fundamental recognition.